Pure Global
NCT06408467

Monitoring of Non-Surgical Treatment of Peri-implantitis

Monitoring of Non-Surgical Treatment of Peri-implantitis, Traditional Measurement Methods and aMMP-8 Test Technology-Cross Sectional Study
Lahanna oy·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Peri-implant Mucositis,Peri-Implantitis
Drug/Device/Intervention
aMMP-8 diagnostic test
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Lahanna oy
Location
Helsinki, Finland
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2022
End date
Nov 15, 2022
Enrollment
40 participants
Primary outcome

the result of the participants who were measured aMMP-8,the result of the participants who were measured BOP,the result of the participants who were measured PPD

Summary

This study aimed to investigate the response to non-surgical treatment of peri-implantitis
 diseases during the maintenance phase. The patients underwent non-surgical implant
 maintenance treatment, and the success of the treatment was measured again after 30 days
 using the same criteria and methods.

ICD-10 classifications
Oral mucositis (ulcerative)Infection and inflammatory reaction due to other internal orthopaedic prosthetic devices, implants and graftsInfection and inflammatory reaction due to prosthetic device, implant and graft in genital tractInfection and inflammatory reaction due to other internal prosthetic devices, implants and graftsPeritonitis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06408467
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06408467 through Pure Global AI's free database. This phase not specified trial is sponsored by Lahanna oy and is currently Completed. The study focuses on Peri-implant Mucositis,Peri-Implantitis. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.